Clinical trial
MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)
NCT00054678 · Bioheart, Inc., Industry · Unknown status
Key facts
| NCT number | NCT00054678 |
|---|---|
| Title | MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial) |
| Official title | A Phase I, Open-Label, Non-Randomized, Dose Escalation, Multi Center Study to Assess the Safety and Cardiovascular Effects of Autologous Skeletal Myoblast Implantation by a Transendocardial Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s) With Previous… |
| Lead sponsor | Bioheart, Inc., Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure, Coronary Artery Disease, Myocardial Infarction |
| Intervention type | Device, Drug |
| Interventions | MyoCell™, MyoCath™ |
| Enrollment | 20 |
| Start date | Feb 1, 2003 |
| Completion | Oct 1, 2007 |
| First posted | Feb 7, 2003 |
| Last update posted | Oct 15, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: